Mariella Damiano, MD
Affiliations: | Pharmacology | University of Paris-Sud 11 (Orsay) |
Google:
"Mariella Damiano"Mean distance: 17.48 (cluster 28)
Cross-listing: Chemistry Tree
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Damiano M, Gautier CA, Bulteau AL, et al. (2014) Tissue- and cell-specific mitochondrial defect in Parkin-deficient mice. Plos One. 9: e99898 |
| Buhlman L, Damiano M, Bertolin G, et al. (2014) Functional interplay between Parkin and Drp1 in mitochondrial fission and clearance. Biochimica Et Biophysica Acta. 1843: 2012-26 |
| Damiano M, Diguet E, Malgorn C, et al. (2013) A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin. Human Molecular Genetics. 22: 3869-82 |
| Neymotin A, Calingasan NY, Wille E, et al. (2011) Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis. Free Radical Biology & Medicine. 51: 88-96 |
| Damiano M, Galvan L, Déglon N, et al. (2010) Mitochondria in Huntington's disease. Biochimica Et Biophysica Acta. 1802: 52-61 |
| Magrané J, Hervias I, Henning MS, et al. (2009) Mutant SOD1 in neuronal mitochondria causes toxicity and mitochondrial dynamics abnormalities. Human Molecular Genetics. 18: 4552-64 |
| Petri S, Kiaei M, Damiano M, et al. (2006) Cell-permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis. Journal of Neurochemistry. 98: 1141-8 |
| Damiano M, Starkov AA, Petri S, et al. (2006) Neural mitochondrial Ca2+ capacity impairment precedes the onset of motor symptoms in G93A Cu/Zn-superoxide dismutase mutant mice. Journal of Neurochemistry. 96: 1349-61 |